Page 5 - Rems Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rems program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rems Program Today - Breaking & Trending Today

TG Therapeutics, inc (TGTX) Q2 2021 Earnings Call Transcript


Greetings. Welcome to TG Therapeutics Second Quarter 2021 Earnings Call and Business Update. [Operator Instructions]
At this time, I will now turn the conference over to Jenna Bosco, Senior Vice President of Corporate Communications. Jenna, you may now begin.
Jenna Bosco
Senior Vice President, Corporate Communications
Thank you. Welcome everyone and thanks for joining us this morning. I m Jenna Bosco and with me today to discuss the second quarter 2021 financial results and provide a business update are Michael Weiss, our Chairman and Chief Executive Officer; Adam Waldman, our Chief Commercialization Officer; and Sean Power, our Chief Financial Officer. Following our Safe Harbor statement, Mike will provide an overview of our recent corporate developments as well as an update on our current pivotal programs and remaining key goals for 2021. Adam will then provide an update on our commercialization efforts and Sean will provide a brief overview of our financial r ....

New York , United States , Chris Howerton Jefferies , Matt Kaplan , Josh Schimmer Evercore , Graig Suvannavejh , Mayank Mamtani , Michael Weiss , Paul Barr , Alethia Young , Alethia Young Cantor Fitzgerald , Michaels Weiss , Red White , Adam Waldman , Matt Kaplan Ladenburg Thalmann , Josh Schimmer , Chris Howerton , Sean Power , Mike Weiss , Jenna Bosco , Mayank Mamtanib Riley , Deric Joseph , Eric Joseph Jpmorgan , Graig Suvannavejh Goldman Sachs , European Academy Of Neurology Annual Meeting , Ladenburg Thalmann ,

How One Woman Fought Treatment-Resistant Depression


How One Woman Fought Treatment-Resistant Depression
March 3, 2021
FacebookTwitterEmail
(BPT) - For years before her diagnosis, Nicole thought her daily routine was normal. Habits like sleeping for 18 hours a day, missing school and struggling to maintain friendships just seemed like hallmarks of an “angsty” personality, as many in her life had labeled her. “It wasn’t until my mom became worried about me and started taking me to doctors and psychiatrists that I began to realize I wasn’t actually totally fine,” she said.
After seeking help, Nicole learned that for years, she was actually fighting an invisible illness – a type of depression called major depressive disorder (MDD). Impacting nearly 17 million adults in the U.S., MDD is a serious, biologically based disease that has a major impact on the way people think, feel, and act. ....

United States , National Institute Of Mental Health , National Pregnancy Registry For Antidepressants , Janssen Pharmaceuticals Inc , Agency For Healthcare Research , Methods In Clinical Research , Risk Evaluation , Mitigation Strategy , National Pregnancy Registry , Prescribing Information , Medication Guide , Janssen Pharmaceuticals , Major Depressive Episode Among , Accessed December , Healthcare Research , Treatment Resistant Depression , Systematic Review , Clinical Research , Rush Aj , Agency For Healthcare Research And Quality , Treatment Resistant Depressiona Narrative And Systematic Review Of Definitions Methods In Clinical Research Studies , One Woman Fought Treatment Resistant Depression , Share Network , Rems Program , Spravato Risk Evaluation And Mitigation Strategy , Amj Psychiatry ,